Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma.

Zheng Du,Huaqi Yin,Shiming Zhao,Yongkang Ma,Zhenghui Sun,Bingqi Dong,Mingkai Zhu,Chaoshuai Zhu,Jiangshan Peng,Tiejun Yang

Frontiers in oncology（2022）

引用 0|浏览9

暂无评分

摘要

Gemcitabine intravesical hyperthermia therapy combined with intravenous tislelizumab in the treatment of muscle invasive bladder urothelium carcinoma may provide a new possible therapeutic strategy of some patients who are inoperable or refuse surgery.

查看译文

关键词

bladder hyperthermia,chemotherapy,gemcitabine,muscle invasive bladder urothelium carcinoma,tislelizumab,tumor immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要